{"id":"W2474984667","doi":"10.1002/cncr.30137","title":"Randomized phase 3 study in low‐grade lymphoma comparing maintenance anti‐CD20 antibody with observation after induction therapy: A trial of the ECOG‐ACRIN Cancer Research Group (E1496)","year":2016,"lang":"en","type":"article","venue":"Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Hazard ratio; Rituximab; Internal medicine; Follicular lymphoma; Vincristine; Clinical endpoint; Induction chemotherapy; Prednisone; Surgery; Maintenance therapy; Cyclophosphamide; Gastroenterology; Randomized controlled trial; Lymphoma; Oncology; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002607221,0.001266622,0.00235488,0.0004092486,0.0003836795,0.000955482,0.0009956814,0.001715235,0.006078666],"category_scores_gemma":[0.001748708,0.000382523,0.001665127,0.0004027791,0.0008886416,0.0007616429,0.0004630916,0.003175264,0.0008644472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009620063,"about_ca_system_score_gemma":0.001253049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133161,"about_ca_topic_score_gemma":0.002166028,"domain_scores_codex":[0.9991592,0.0005602933,0.00003055108,0.0001010399,0.00005000683,0.00009897888],"domain_scores_gemma":[0.9986961,0.0003627573,0.0003199019,0.00009678197,0.00006200116,0.0004624556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9815221,0.004612346,0.000858298,0.0001781157,0.000442368,0.00003747272,0.00003305329,0.0001955828,0.001445941,0.00008597534,0.0009305549,0.009658121],"study_design_scores_gemma":[0.9533031,0.04340922,0.001953867,0.00001873859,0.0001736826,0.00003833132,0.00001025098,0.0002454209,0.0002101929,0.00009532556,0.0005354036,0.000006349321],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867683,0.004167915,0.0004920646,0.0009509719,0.0004162563,0.003674234,0.001509709,0.0001196566,0.001900919],"genre_scores_gemma":[0.9818116,0.002032157,0.002034786,0.002526173,0.0004036459,0.00565453,0.002443898,0.00003497539,0.003058221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006078666,"threshold_uncertainty_score":0.02033514,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09838738969729825,"score_gpt":0.4047319849806768,"score_spread":0.3063445952833785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}